Cargando…

Role of GALNT4 in protecting against cardiac hypertrophy through ASK1 signaling pathway

Pathological myocardial hypertrophy is regulated by multiple pathways. However, its underlying pathogenesis has not been fully explored. The goal of this work was to elucidate the function of polypeptide N-acetylgalactosaminyltransferase 4 (GALNT4) in myocardial hypertrophy and its underlying mechan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Bin-Bin, Gao, Lu, Yang, Qin, Liu, Yuan, Yu, Xiao-Yue, Shen, Ji-Hong, Zhang, Wen-Cai, Han, Zhan-Ying, Chen, Shao-Ze, Guo, Sen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531281/ https://www.ncbi.nlm.nih.gov/pubmed/34675184 http://dx.doi.org/10.1038/s41419-021-04222-5

Ejemplares similares

Dual-specificity Phosphatase 9 protects against Cardiac Hypertrophy by targeting ASK1
por: Jiang, Lang, et al.
Publicado: (2021)

Asiatic Acid Protects against Cardiac Hypertrophy through Activating AMPKα Signalling Pathway
por: Ma, Zhen-Guo, et al.
Publicado: (2016)

Testin protects against cardiac hypertrophy by targeting a calcineurin‐dependent signalling pathway
por: Gao, Lu, et al.
Publicado: (2018)

Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway
por: Cai, Jun, et al.
Publicado: (2010)

Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway
por: Cai, Jun, et al.
Publicado: (2009)

Si-Miao-Yong-An Decoction Protects Against Cardiac Hypertrophy and Dysfunction by Inhibiting Platelet Aggregation and Activation
por: Su, Congping, et al.
Publicado: (2019)

Tanshinone IIA Protects Against Cardiac Hypertrophy via Inhibiting Calcineurin/Nfatc3 Pathway
por: Tan, Xueying, et al.
Publicado: (2011)

Choline Protects Against Cardiac Hypertrophy Induced by Increased After-load
por: Zhao, Yilei, et al.
Publicado: (2013)

ICS II protects against cardiac hypertrophy by regulating metabolic remodelling, not by inhibiting autophagy
por: Han, Dongjian, et al.
Publicado: (2020)

Slowing Heart Rate Protects Against Pathological Cardiac Hypertrophy
por: Sebastian, Sonia, et al.
Publicado: (2022)

Bakuchiol protects against pathological cardiac hypertrophy by blocking NF-κB signaling pathway
por: Wang, Zheng, et al.
Publicado: (2018)

Zinc-finger protein 418 overexpression protects against cardiac hypertrophy and fibrosis
por: Pan, Liming, et al.
Publicado: (2017)

Galnt1 Is Required for Normal Heart Valve Development and Cardiac Function
por: Tian, E, et al.
Publicado: (2015)

Angiotensin‐Converting Enzyme 3 (ACE3) Protects Against Pressure Overload‐Induced Cardiac Hypertrophy
por: Yu, Chang‐Jiang, et al.
Publicado: (2016)

Pioglitazone Protected against Cardiac Hypertrophy via Inhibiting AKT/GSK3β and MAPK Signaling Pathways
por: Wei, Wen-Ying, et al.
Publicado: (2016)

Sanggenon C protects against pressure overload-induced cardiac hypertrophy via the calcineurin/NFAT2 pathway
por: Xiao, Lili, et al.
Publicado: (2017)

H(2)S Protects against Cardiac Cell Hypertrophy through Regulation of Selenoproteins
por: Greasley, Adam, et al.
Publicado: (2019)

Protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats through inhibiting the Cys-C/Wnt signaling pathway
por: Feng, Jun, et al.
Publicado: (2016)

Sodium Ferulate Protects against Angiotensin II-Induced Cardiac Hypertrophy in Mice by Regulating the MAPK/ERK and JNK Pathways
por: Hu, Bo, et al.
Publicado: (2017)

SIRT2 inhibition protects against cardiac hypertrophy and ischemic injury
por: Yang, Xiaoyan, et al.
Publicado: (2023)

High Expression of N-Acetylgalactosaminyltransferase 1 (GALNT1) Associated with Invasion, Metastasis, and Proliferation in Osteosarcoma
por: Zhang, Liwen, et al.
Publicado: (2020)

Hydroxysafflor yellow A protects against angiotensin II-induced hypertrophy
por: Ni, Bin, et al.
Publicado: (2018)

Diosmetin Protects against Cardiac Hypertrophy via p62/Keap1/Nrf2 Signaling Pathway
por: Guo, Yingying, et al.
Publicado: (2022)

Apelin-36 protects against lipopolysaccharide-induced acute lung injury by inhibiting the ASK1/MAPK signaling pathway
por: He, Qiong, et al.
Publicado: (2021)

Ca(2+)/Calmodulin-Dependent Protein Kinase II Regulation by Inhibitor of RIPK3 Protects against Cardiac Hypertrophy
por: Zhang, Jingjing, et al.
Publicado: (2022)

Oridonin protects against cardiac hypertrophy by promoting P21-related autophagy
por: Xu, Man, et al.
Publicado: (2019)

Glucosylceramide synthase inhibition protects against cardiac hypertrophy in chronic kidney disease
por: Baccam, Gabriel C., et al.
Publicado: (2022)

Astragaloside IV Exerts a Myocardial Protective Effect against Cardiac Hypertrophy in Rats, Partially via Activating the Nrf2/HO-1 Signaling Pathway
por: Nie, Pei, et al.
Publicado: (2019)

Andrographolide Protects against Aortic Banding-Induced Experimental Cardiac Hypertrophy by Inhibiting MAPKs Signaling
por: Wu, Qing Q., et al.
Publicado: (2017)

Renal replacement therapy after cardiac surgery: do not ask “When”, ask “Why”
por: Gaudry, Stéphane, et al.
Publicado: (2017)

Cardiac LXRα protects against pathological cardiac hypertrophy and dysfunction by enhancing glucose uptake and utilization
por: Cannon, Megan V, et al.
Publicado: (2015)

CYP2J2 Overexpression Protects against Arrhythmia Susceptibility in Cardiac Hypertrophy
por: Westphal, Christina, et al.
Publicado: (2013)

Dual‐Specificity Phosphatase 26 Protects Against Cardiac Hypertrophy Through TAK1
por: Zhao, Jing, et al.
Publicado: (2021)

Transmembrane protein 117 knockdown protects against angiotensin-II-induced cardiac hypertrophy
por: Yang, Yi, et al.
Publicado: (2023)

Aerobic exercise protects against pressure overload-induced cardiac dysfunction and hypertrophy via β3-AR-nNOS-NO activation
por: Wang, Bin, et al.
Publicado: (2017)

Deletion of ASK1 Protects against Hyperoxia-Induced Acute Lung Injury
por: Fukumoto, Jutaro, et al.
Publicado: (2016)

The Protective Effect of Aspirin against Myocardial Hypertrophy in Rats
por: Wu, Xiaolong, et al.
Publicado: (2021)

Protective effect of hydrogen sulphide against myocardial hypertrophy in mice
por: Shao, Mingjing, et al.
Publicado: (2017)

Protections of transcription factor BACH2 and natural product myricetin against pathological cardiac hypertrophy and dysfunction
por: Jiang, Xueli, et al.
Publicado: (2022)

GALNT2 regulates ANGPTL3 cleavage in cells and in vivo of mice
por: Li, Xuedan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sknrn7lfpeereqvpat9k3bffcu